Clinical Trial Update: Efficacy and Safety Study of Seroquel SR in the Treatment of Generalized Anxiety Disorder [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of Seroquel SR (quetiapine extended-release) for generalized anxiety disorder has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder

Drugs mentioned

• Seroquel SR (quetiapine extended-release)

Snippet

Sponsor: AstraZeneca | Conditions: Generalized Anxiety Disorder | Phase 3 | Status: COMPLETED